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Introduction
Findings that nicotine is an antinociceptive agent in animals (Aceto et al., 1986) , and that cigarette smoking and nicotine reduce pain in humans (Lane et al., 1995; Jammer et al., 1998) suggest that nicotinic compounds might be useful in the treatment of pain. Furthermore, the observation that the nicotinic agonist epibatidine is 100 times more potent than morphine as an analgesic in the tail-flick and hot-plate tests (Spande et al., 1992) has spurred renewed interest in the development of nicotinic agents as analgesics (Flores and Hargreaves, 1998) . Analgesic drugs currently used produce serious side effects upon long-term use, safer and more efficacious analgesic agents are needed. It is generally agreed that central pathways modulate the analgesic actions of nicotine (Sahley and Berntson, 1979) ; in particular, the spinal cord is a major site of action for tail-flick nociception given that intrathecal administration of nicotinic agonists produces antinociception in this test (Aceto et al., 1986; Christensen and Smith, 1990 ). In addition, Caggiula et al. (1995) suggested that nicotine's effects on the tail-flick and hot-plate tests involve at least partially separate pathways. Unfortunately, only limited progress has been made towards identifying the neuronal nicotinic acetylcholine receptor (nAChR) subtypes expressed in spinal cord that modulate pain, perhaps because mRNAs for virtually all of the nAChR subtypes have been identified in dorsal root ganglion neurons of adult (Haberberger et al., 2004) and neonatal mice (Cordero-Erausquin et al., 2004) . This complexity might explain why studies using pharmacological approaches to identify the nAChR subtypes that modulate the antinociceptive effects of nicotinic agonists (Damaj et al., 1999) and antagonists (Iwamoto and Marion, 1993) are not in complete agreement.
Studies using nAChR subunit null mutant (gene knock-out) mice have suggested roles for specific nAChRs subtypes in nicotine-induced antinociception. Mice lacking either the α 4 or β 2 nicotinic receptor subunit showed reduced sensitivity to nicotine-induced antinociception in the hot-plate and tail-flick acute pain tests (Marubio et al. 1999 ). Both α 4 and β 2 null mutant mice failed to respond to nicotine on the hot-plate test at doses that were fully efficacious in WT mice, suggesting a prominent role for α 4 β 2 -nAChR. In contrast, both α 4 and β 2 gene deletion resulted in only modest (2-3 fold) reductions in agonist potency with the tail-flick test.
The present study used two genetic approaches to investigate which nAChR subtypes modulate the actions of nicotine on the hot-plate and tail-flick tests. The first approach took advantage of knock-in mice that express mutated α 4 *-nAChRs (Labarca et al., 2001 ). These mice express α 4 subunits with a leucine to serine substitution in the 9' position (L9'S) of the pore-lining M2 region, which renders mice hypersensitive to nicotine in functional and behavioral tests (Labarca et al, 2001; Fonck et al., 2003) . The second approach took advantage of the findings that This article has not been copyedited and formatted. The final version may differ from this version.
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JPET # 112649 5 outbred and inbred mouse strains differ in sensitivity to the effects of nicotine (Seale et al., 1998) and epibatidine on thermal reactivity tests (Flores et al., 1999) , locomotor activity (Collins et al., 1988; Marks et al., 1989) , hypothermia (Tritto et al., 2001 ) and seizures (Miner and Collins, 1989) . Mouse strains also differ in brain [
3 H]-nicotine (α 4 β 2 *-nAChRs) (Marks et al., 1989) and [ 125 I]-α-bungarotoxin (α 7 -nAChRs) binding (Stitzel et al., 1998 ≈ 20 pM) radiolabeled-epibatidine binding, which can be divided into two major components based on the sensitivity to inhibition by cytisine. The fraction sensitive to cytisine inhibition is primarily comprised of the α 4 β 2 subtype whereas cytisine-resistant sites are thought to represent α 3 β 2 *, α 3 β 4 * and α 6 β 2 * receptors (Marks et al., 2006) . The observation that strain variability in responses to nicotine is significantly correlated with differences in binding of radioactive nicotinic ligands, prompted us to study the effects of nicotine on the hot-plate and tail-flick tests of seven inbred mouse strains known to be differentially sensitive to nicotine for other measures (Marks et al. 1989) as well as for two F1 hybrids. We then measured cytisine-sensitive and cytisine- 
Materials and Methods
Animals. Generation of the L9'S strain, by replacing the native α4 subunit of nAChR with a mutated form, was previously described (Labarca et al., 2001) . Only heterozygous L9'S mice with an intact neomycin resistance cassette were used because L9'S homozygous are neonatal lethal, therefore the L9'S designation used throughout the paper refers to these heterozygotes. Male mice from the following inbred strains were used: C57BL/6J, DBA/2JIbg, A/J, CBA/J, C3H/HeJ, BALB/cByJ, 129/SvEv, B6CBAF1 and B6D2F1. DBA/2JIbg mice were obtained from the breeding colony at the Institute for Behavioral Genetics (Boulder, CO). The 129/SvEv strain was obtained from Taconic (Germantown, NY). The remaining strains were purchased from Jackson Laboratories (Bar Harbor, ME) and housed in the mouse colony at the Institute for Behavioral Genetics for at least two weeks prior to testing. Mice were housed in groups of three to four per cage and had free access to food and water. All animals were 60-90 days of age at the time of testing. The study was reviewed and approved by the Institutional Animal Morphine sulphate and (-)-nicotine were obtained from Sigma-Aldrich (St. Louis, MO). All drugs were dissolved in physiological saline (0.9% sodium chloride), and all doses are expressed as the free base of the drug.
Antinociceptive tests.
1. Tail-flick test. Mice were lightly restrained by hand while a radiant heat light source was shone onto the upper portion of the tail. Latency to remove the tail from the heat source was recorded for each animal. A control response (2-4 s latency) was determined for each mouse before treatment, and test latency was determined after drug administration. In order to minimize tissue damage, a maximum latency of 10 sec was imposed.
Antinociceptive response was calculated as percent of maximum possible effect (% MPE), where %MPE = [(test value -baseline)/(cut-off time (10 s) -control value)] X 100 where baseline represents the value before nicotine.
Groups of eight to twelve animals were used for each dose and for each treatment. Mice were tested 5 min after a subcutaneous (s.c.) injection of nicotine.
This article has not been copyedited and formatted. The final version may differ from this version. In order to assess specificity of the nicotine-induced analgesia in L9'S, animals were injected with mecamylamine (1 mg/kg, s.c.), 5 min before receiving a single nicotine injection in the hot-plate and the tail-flick tests. For comparison purposes, the specificity of nociceptive responses in L9'S mice was also evaluated by determining the potency of morphine in the hot-plate and the tail-flick tests. Animals were tested 20 min after a s.c.
injection of morphine.
Binding Experiments
1. Tissue Preparation. Mice were killed by cervical dislocation. Their brains were removed and placed on ice and the hindbrains (pons medulla) were dissected. The spinal column was isolated and divided into thoracic, cervical and lumbar regions. Each segment of the spinal cord was removed from the spinal column by gentle flushing with ice cold, isotonic saline. The dissected tissue was subsequently placed in hypotonic buffer (14 mM NaCl, 0.2 mM KCl, 0.2 mM CaCl 2 , 0.1 mM MgSO 4 , 2 mM HEPES, pH=7.5). Samples were homogenized using a glass-teflon tissue grinder. Homogenized samples were centrifuged at 10 000 x g for 20 min and the supernatant was discarded. The pellet was re-suspended in hypotonic buffer and centrifuged again at 10 000 x g for 20 min.
This procedure was repeated two more times. The final washed pellet was re-suspended in dilute buffer to a concentration of 1 -2 mg protein/ml. 
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8 presence of 0 nM, 50 nM and 150 nM cytisine. Blanks were established using 0.1 mM nicotine. Blanks represented less than 5% if specific binding. Following the incubation, samples were filtered using an Inotech harvester and two layers of glass fiber filter (top filter MFS GC, bottom filter Gelman A/E both of which had been soaked in 0.1% polyethylenimine). Samples were washed six times with ice cold buffer without serum albumin.
Samples were counted using a Packard Tri-Carb liquid scintillation spectrometer at 45% efficiency after the addition of 1.5 ml of Budget Solve scintillation cocktail (RBI).
[
125 I]-α-BTX Binding.
[ 125 I]-α-BTX (specific activity = 200 Ci/mmol, NEN) binding was essentially measured as described previously . Samples were incubated for 3 hr in 100 µl of buffer ( Although maximal binding is not measured at this concentration, use of higher ligand concentrations resulted in very unfavorable signal/noise ratios. Following the incubation, samples were filtered using an Inotech harvester and two layers of glass fiber filter (top filter MFS GC, bottom filter Gelman A/E both of which had been soaked in 0.1% polyethylenimine). Samples were washed six times with ice-cold buffer without serum albumin. Samples were counted using a Packard gamma counter at 80% efficiency.
4. Protein. Protein was measured with the method of Lowry et al., (1951) , using bovine serum albumin as the standard.
Statistical analysis. Statistical analysis of all behavioral studies was performed using either a t-test or analysis of variance (ANOVA) with a Dunnett's t-test post hoc test when appropriate. All differences were considered significant at p < 0.05. ED 50 values with a 95% confidence level (CL) for behavioral data were calculated by unweighted least-squares linear regression as described by Tallarida and Murray (1987) . One-way ANOVA followed by Dunnett's post hoc t-test was used to evaluate differences in binding in each tissue for each binding site. Relationships among the parameters were assessed by linear regression.
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Results

Antinociceptive Effects of Nicotine in the α4 L9'S mice
Antinociceptive effects of nicotine on L9'S heterozygous and wild-type mice in the tail-flick and hot-plate tests are shown in Figures 1A and 1B . The latency response of non-injected control mice to a painful stimulus did not differ significantly between WT and L9'S animals in either test, indicating that the endogenous activation of the α4 nAChR subunit, even with a mutation conferring hypersensitivity, is not essential to the perception of acute thermal nociception.
The tail-flick test revealed no obvious hypersensitivity to nicotine in the L9'S mice ( Figure 1A ) after s.c.
injection of various doses of nicotine. However, it should be noted that doses higher than 0.5 mg/kg were not tested in L9'S mice because animals displayed tremors, shaking and stereotypy when higher doses of nicotine were administered (Fonck et al, 2003) . These behavioral responses in L9'S mice are thought to precede seizures, which are likely initiated in subcortical structures such as the hippocampus, thalamus or medial habenula and are not thought to be directly involved in antinociceptive responses. WT mice exhibited a dose-dependent antinociception following nicotine administration at does greater that 0.5 mg/kg. In the hot-plate test ( Figure 1C ), WT mice showed a dose-dependent antinociceptive response with an ED 50 (± CL) = 0.92 (0.7-1.1) mg/kg. In L9'S mice, the nicotine dose-response relation was shifted to the left with an ED 50 value of 0.17 (0.1-0.2) mg/kg ( Figure 1C ). Thus, a 6-fold shift in the dose-response relation for nicotine-induced antinociception was observed between L9'S and WT mice.
The nicotinic receptor antagonist mecamylamine (1 mg/kg) effectively blocked nicotine-induced analgesia described in these experiments. Mecamylamine blocked the nicotine-induced decrease in hot-plate nociception (data not shown) in both L9'S and WT animals. Mecamylamine also blocked the nicotine-induced delay in tail-flick responses in WT mice.
Antinociceptive effects of morphine in the hot-plate and tail-flick tests are shown in Figure 1B and 1D.
L9'S and WT mice had similar dose-dependent antinociceptive responses to morphine in the hot-plate test ( Figure   1D ), yielding ED 50 values of 6.8 (5.8-7.9) and 5.9 (4.8-7.1) mg/kg, respectively. Similar potency for morphine was also observed for L9'S and WT mice in the tail-flick ( Figure 1B Antinociceptive effects were also measured with two F1 hybrids. As was the case with the tail-flick test, the B6D2F1 (F1 cross of C57BL/6 and DBA/2) were slightly more sensitive to nicotine [ED 50 (95%CL)= 0.68(0.2-1.1) mg/kg] than the parental strains, while B6CBAF1 (F1 cross of C57BL/6 and CBA) were significantly less sensitive than either parent (40%MPE after a dose of 3.5 mg/kg).
Receptor Determinations in seven inbred mouse strains
The density of three nicotinic binding sites was measured to explore possible relationships between nAChR levels and sensitivity to nicotine in the mouse strains studied. Binding was measured in hindbrain and the cervical, Significant differences in binding site density among the seven strains were observed (hindbrain, F(6,44)=2.34, p<0.05; thoracic spinal cord, F(6,44)=2.84, p<0.05; and lumbar spinal cord, F(6,44)=2.37, p<0.05; however, cervical spinal cord was not significant, F96,44)=2.01, P>0.05)). In every sample prepared, tissue prepared from A/J mice had the highest densities. Binding for A/J mice was significantly higher that that for CBA and C3H mice in every region. Relative binding site densities measured for tissue obtained from DBA/2 and C57BL/6 mice were similar to each other and varied among the regions. Binding for these two strains was relatively high in hindbrain, cervical and thoracic spinal cord, similar in magnitude to that of the A/J mice.
This article has not been copyedited and formatted. The final version may differ from this version. (Marks et al., 1998) . Results for these measurements are shown in Figure 4 . 
Discussion
Nicotinic agonists elicit antinociceptive responses in several acute pain tests, including tail-flick and hotplate tests. Responses to the hot-plate are thought to be centrally mediated, whereas the tail-flick is considered a spinal reflex (Caggiula et al., 1995) . This study takes advantage of the rare opportunity to study a behavioral test by exploiting both specific targeted mutations in a candidate molecule, and inbred strains that differ in many more genes. The studies reported here further tested the postulate that activation of α 4 β 2 * nAChRs evoke the antinociceptive effects of nicotine on the hot-plate and tail-flick tests.
Previous data based on gene knockouts (Marubio et al., 1999) and on antisense-mediated knockdown (Bitner et al., 2000) indicate that α 4 * and β 2 * receptors are necessary for a major antinoceptive component as measured in the hot plate test; but the present finding that L9'S mice, which express a hypersensitive α 4 receptor, are much more sensitive to the effects of nicotine in the hot-plate test than are the controls, show that nicotine activation of α 4 * receptors mice is sufficient to produce such antinociception. Thus, the combination of necessity and sufficiency does provide compelling indications that, among the set of nAChR receptor subtypes, α 4 β 2 * nAChRs dominate nicotine's actions on the hot-plate test. Marubio et al. (1999) observed that α 4 and β 2 null mutant mice were 2-to 3-fold less sensitive to nicotine than WT mice on the tail-flick test and concluded that the effects of nicotine on this test are modulated by the α 4 β 2 * nAChR subtype plus another, lower affinity nAChR. We did not detect an increase in sensitivity to nicotine's analgesic effects on the tail-flick test in L9'S mice. However, L9'S could not be tested with the full range of nicotine doses. The highest dose that was tested (0.5 mg/kg) produced no measurable change in response in either WT or mutant mice. The higher doses (1.0 and 2.0 mg/kg), which elicited effects in WT mice, were not used in L9'S because doses that exceed 0.5 mg/kg elicit tremors, shaking, stereotypy and convulsions in these mice (Fonck et al., 2003) . Thus, the data obtained with the L9'S mutant mice support the assertion that α 4 β 2 * nAChRs play a more dominant role in regulating nicotine's effects on the hot-plate test than for the tail-flick response.
Studies with both knock-out and knock-in mice provide valuable insights into the role of α 4 *-nAChRs in pain modulation, but adaptive changes elicited by these mutations could affect the nociceptive phenotype. For example, the number of dopamine neurons in the substantia nigra is reduced by ~35% in adult L9'S mice (Orb et al., 2004 ) and α 4 null mutant mice exhibit alterations in arborization of the dendrites of dopamine neurons (Parish et al., 2005) . These concerns prompted us to evaluate the effects of nicotine in seven inbred mouse strains to evaluate the variation in nicotine-induced antinociception.
This article has not been copyedited and formatted. The final version may differ from this version. Inbred mouse strains also vary substantially in sensitivity to nicotine, as measured by a battery of behavioral tests and the seven inbred strains selected for the current study represent a wide range of sensitivity to nicotine (Marks et al., 1989 ). The seven strains tested also differed markedly in sensitivity to the effects of nicotine in both the hot-plate and tail-flick tests. Indeed, the 7.5-fold difference in sensitivity to nicotine's effects on the hotplate test between the most sensitive (A/J) and the least sensitive (CBA) inbred strains was as great as the difference between the L9'S and their WT littermates. These results are consistent with the finding that inbred mouse strains exhibit a 4-fold variation in sensitivity to epibatidine-induced antinociception for the tail-immersion withdrawal thermal assay, with the A/J strain being the most sensitive (Flores et al., 1999) . (Damaj et al., 2000) .
These results suggest that the α 7 nAChR may be the lower affinity receptor that also modulates the tail-flick test.
Inbred strain differences in drug sensitivity could be attributed to pharmacodynamic or pharmacokinetic differences. Nicotine metabolism and elimination do not differ among several of these inbred strains (Petersen et al., 1984) . Therefore, it is reasonable to assume that the pharmacogenetic variability observed in our studies is due to differences in nicotinic receptors or any of the various downstream mechanisms engaged by these receptors. In particular, although the L9'S mice have a subset of α4* receptors that bear a mutation conferring a difference in ACh sensitivity, it seems possible that overall ACh sensitivity can also be governed by straightforward differences in the number of receptors. Inbred mouse strains differ in the number of brain nAChRs, as measured by high affinity (Marks et al., 1989) . Indeed, differences in binding site density are significantly correlated with differences in effects of nicotine on maze activities and hypothermia (Marks et al., 1989) . These results prompted us to examine the potential associations between nicotine-induced antinociception and brain stem/spinal cord nAChR numbers.
We measured nAChR binding in the spinal cord and the hindbrain, using [
I]-epibatidine and [
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16 nAChRs (Marks et al., 2006 (Marks et al., 1989) . It is also likely that nicotineevoked responses in these complex behavioral assays depend on downstream events not directly related to receptor levels. Such a possibility is reinforced by the results with the F1 hybrids, where the B6CBAF1 showed striking overdominance toward resistance to nicotine, while the B6D2F1 showed modest dominance toward sensitivity.
Such complex inheritance patterns for nicotine-mediated behavioral responses have been observed for both nicotineinduced locomotor and hypothermic (Marks et al., 1985) responses.
nAChRs are known to mediate release of several neurotransmitters and neuropeptides such as ACh, serotonin and norepinephrine (Wonnacott et al., 1996) , thus differences in these parameters could contribute to the strain difference observed. Alternatively activation of the endogenous opiate system may occur downstream from α 4 β 2 * nAChRs. Many studies have addressed the question of whether nicotinic agonists elicit their antinociceptive effects via interaction with endogenous opiate systems. There is substantial evidence that nicotinic agonists increase release of endogenous opiates and increase their synthesis in the brain (Houdi et al., 1998) . The findings that pretreatment with opiate antagonists inhibits the antinociceptive effects of nicotine in rats (Biala et al., 2005) and mice (Berrendero et al., 2002) , and the observation that preproenkephalin knock-out mice exhibit decreased sensitivity to nicotine's effects on tail-immersion and hot-plate tests (Berrendero et al., 2005) , suggest that nicotinic agonists exert some of their analgesic effects via endogenous opiate release. However, we did not find any change in sensitivity to the effects of morphine on either the hot-plate or tail-flick tests in L9'S mutant mice. Similarly, α 4 knock-out mice did not show a detectable change in sensitivity to the effects of morphine on the hot-plate and tailflick tests (Marubio et al., 1999) . These findings argue that opiate analgesia does not require direct activation of α 4 *-nicotinic receptors.
In summary, the studies reported here provide a new dimension that complements the conclusions drawn from the α 4 and β 2 knock-out studies (Marubio et al., 1999) . Taken together, studies using knock-out, gain-of- Legends for Figures   Fig. 1 Dose-response curves of nicotine and morphine-induced antinociception in L9'S heterozygote (dark grey circles) and WT (black circles) mice. Animals were tested in the hot-plate and the tailflick apparatus as described in Materials and Methods. Animals were tested 5 min after a s.c.
nicotine injection in A) the tail-flick and B) hot-plate tests. Each data point is the mean ± S.E. of n = 6-8 animals. A different set of animals was tested 20 min after a s.c. morphine injection in B)
the tail-flick and D) hot-plate tests. Each data point is the mean ± S.E., n = 6 -8. 
24 of the spinal cord was measured using 400 pM ligand in membranes prepared from the seven different inbred mouse strains and the two F1 hybrids as described in the Methods. Results are expressed in fmol/mg protein ± SE for preparations from five mice of each strain. 
